AUROLIFE PHARMA LLC FDA Approval ANDA 085219

ANDA 085219

AUROLIFE PHARMA LLC

FDA Drug Application

Application #085219

Application Sponsors

ANDA 085219AUROLIFE PHARMA LLC

Marketing Status

Discontinued001

Application Products

001TABLET;ORAL50MG0HYDROCHLOROTHIAZIDEHYDROCHLOROTHIAZIDE

FDA Submissions

ORIG1AP1979-03-12
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1982-09-30
MANUF (CMC); Manufacturing (CMC)SUPPL9AP1987-04-06
MANUF (CMC); Manufacturing (CMC)SUPPL12AP1987-04-06
LABELING; LabelingSUPPL14AP1989-11-02
MANUF (CMC); Manufacturing (CMC)SUPPL16AP1995-03-28
LABELING; LabelingSUPPL17AP1992-10-19
LABELING; LabelingSUPPL18AP1993-03-29
LABELING; LabelingSUPPL19AP1993-08-17

Submissions Property Types

SUPPL7Null0
SUPPL9Null0
SUPPL12Null0
SUPPL16Null0

CDER Filings

AUROLIFE PHARMA LLC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 85219
            [companyName] => AUROLIFE PHARMA LLC
            [docInserts] => ["",""]
            [products] => [{"drugName":"HYDROCHLOROTHIAZIDE","activeIngredients":"HYDROCHLOROTHIAZIDE","strength":"50MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"HYDROCHLOROTHIAZIDE","submission":"HYDROCHLOROTHIAZIDE","actionType":"50MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.